Mirapex Er | Pramipexole Dihydrochloride Tablet, Extended Release while Breastfeeding
American Academy of Pediatrics and other medical experts exclusively recommend to breastfeed the baby for first 6 months. Once you introduce baby to other foods it is recommended to breastfeed for at least first year of babys life. Taking medication while breastfeeding could be tricky as most drugs pass in breast milk. In this article we will evaluate Mirapex Er | Pramipexole Dihydrochloride Tablet, Extended Release for its safety in breastfeeding.

What is Mirapex Er | Pramipexole Dihydrochloride Tablet, Extended Release used for?


MIRAPEX ER® tablets are indicated for the treatment of Parkinson's disease. MIRAPEX ER is a non-ergot dopamine agonist indicated for the treatment of Parkinson’s disease (PD) (1)

Can I continue breastfeeding if I am using Mirapex Er | Pramipexole Dihydrochloride Tablet, Extended Release? How long does it stays in breast milk?

Mirapex Er | Pramipexole Dihydrochloride Tablet, Extended Release high risk while breastfeeding
As Mirapex Er | Pramipexole Dihydrochloride Tablet, Extended Release is made of only Pramipexole dihydrochloride, and Pramipexole dihydrochloride is unsafe to use in breastfeeding we can safely reach on conclusion that Mirapex Er | Pramipexole Dihydrochloride Tablet, Extended Release is also unsafe to use while breastfeeding. Below is detailed analysis of Pramipexole dihydrochloride and Mirapex Er | Pramipexole Dihydrochloride Tablet, Extended Release during location. We recommend you to go through provided detailed analysis as below take decision accordingly. We also recommend you talk to your health care provider before making final decision.

Mirapex Er | Pramipexole Dihydrochloride Tablet, Extended Release Breastfeeding Analsys


Pramipexole dihydrochloride while Breastfeeding

Unsafe

CAS Number: 104632-26-0

Anti-Parkinson drug, dopamine-agonist (non ergot) used for treatment of restless leg syndrome and Parkinson’s Disease. It may suppress lactation by inhibiting prolactin release.

Mirapex Er | Pramipexole Dihydrochloride Tablet, Extended Release Breastfeeding Analsys - 2


Pramipexole dihydrochloride while Breastfeeding

CAS Number: 104632-26-0

No information is available on the use of pramipexole during breastfeeding, but it suppresses serum prolactin and may interfere with breastfeeding. An alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Mirapex Er | Pramipexole Dihydrochloride Tablet, Extended Release and breastfeeding

I already used Mirapex Er | Pramipexole Dihydrochloride Tablet, Extended Release and meanwhile I breastfed my baby should I be concerned?

If you observer abnormal behavior or any other health issue in infant then you should immediately call 911 or contact other contact other emergency service provider in your area otherwise closely monitor the baby and inform your doctor about your Mirapex Er | Pramipexole Dihydrochloride Tablet, Extended Release usage and time interval of breastfeeding.


My doctor has prescribed me Mirapex Er | Pramipexole Dihydrochloride Tablet, Extended Release, what should I do?

If your doctor knows that you are breastfeeding mother and still prescribes Mirapex Er | Pramipexole Dihydrochloride Tablet, Extended Release then there must be good reason for that as Mirapex Er | Pramipexole Dihydrochloride Tablet, Extended Release is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using Mirapex Er | Pramipexole Dihydrochloride Tablet, Extended Release, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Mirapex Er | Pramipexole Dihydrochloride Tablet, Extended Release and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of Mirapex Er | Pramipexole Dihydrochloride Tablet, Extended Release in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients

Pramipexole Dihydrochloride Tablet
Mirapex | Pramipexole Dihydrochloride Tablet
Pramipexole Dihydrochloride Tablet, Extended Release
Pramipexole Tablet
Mirapex Er | Pramipexole Dihydrochloride Tablet, Extended Release